In detail, del13q patients showed an upregulation of lnc-SEL1L3-1, lnc-AMZ1-6, lnc-DTNB-2 and lnc-SNX29P2-3 (Supplementary Table S5), which were also downregulated in the comparator normal B-cells with respect to CLL samples (Figure 1c), and the downregulation of lnc-SPRYD7-1, also known as DLEU2. This evidence concerns the gene SNX29P2 and B-cell chronic lymphocytic leukemia.